Loans and Fair Value Measurements - Schedule of Fair Value (Details) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Schedule of Fair Value [Abstract] | ||||
| Fair Value - beginning of period | $ 78,635 | $ 22,746,675 | $ 78,635 | $ 23,334,626 |
| Addition | 101,243 | 101,243 | 23,752 | |
| Change in fair value of derivative liabilities | 17,864 | 17,864 | ||
| Change in fair value of SAFE notes | 17,980,118 | 17,368,415 | ||
| SAFE notes converted into shares | (40,726,793) | (40,726,793) | (40,726,793) | |
| Fair Value - end of period | $ 197,742 | $ 197,742 | ||
| X | ||||||||||
- Definition Change in fair value of SAFE notes. No definition available.
|
| X | ||||||||||
- Definition The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the fair value of derivatives recognized in the income statement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|